SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+8.56%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$188M
AUM Growth
+$188M
(-20%)
Cap. Flow
-$62.9M
Cap. Flow
% of AUM
-33.55%
Top 10 Holdings %
Top 10 Hldgs %
72.79%
Holding
63
New
13
Increased
5
Reduced
5
Closed
15
Top Buys
| 1 |
Medtronic
MDT
|
$9.95M |
| 2 |
STAAR Surgical
STAA
|
$7.63M |
| 3 |
Icon
ICLR
|
$6.6M |
| 4 |
Avantor
AVTR
|
$5.27M |
| 5 |
HSKA
Heska Corp
HSKA
|
$5.24M |
Top Sells
| 1 |
Cencora
COR
|
$32.8M |
| 2 |
GSK
GSK
|
$23.3M |
| 3 |
Sanofi
SNY
|
$13.6M |
| 4 |
Centene
CNC
|
$9.88M |
| 5 |
The Beauty Health Co
SKIN
|
$7.77M |
Sector Composition
| 1 | Healthcare | 86.21% |
| 2 | Financials | 12.47% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSAC
1
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $23.4M | 8.65% | 2,323,000 | – | – |
|
|
BCYC
2
Bicycle Therapeutics
BCYC
$511M
| $20.2M | 7.48% | 683,425 | – | – |
|
3
Cigna
CI
$80.3B
| $17.4M | 6.45% | 52,611 | – | – |
|
4
Organon & Co
OGN
$2.45B
| $16.4M | 6.07% | 587,836 -41,000 | -7% | -$1.15M |
|
5
United Therapeutics
UTHR
$13.8B
| $15.3M | 5.65% | 54,959 +10,000 | +22% | +$2.78M |
|
|
6
Cencora
COR
$56.5B
| $14M | 5.17% | 84,399 -198,000 | -70% | -$32.8M |
|
|
7
Medtronic
MDT
$119B
| $9.95M | 3.68% | +128,000 | New | +$9.95M |
|
|
8
STAAR Surgical
STAA
$1.36B
| $7.63M | 2.82% | +157,129 | New | +$7.63M |
|
|
9
Icon
ICLR
$13.8B
| $6.6M | 2.44% | +33,983 | New | +$6.6M |
|
10
Inogen
INGN
$216M
| $5.65M | 2.09% | 286,692 -234,603 | -45% | -$4.62M |
|
|
11
Avantor
AVTR
$9.18B
| $5.27M | 1.95% | +250,000 | New | +$5.27M |
|
|
HSKA
12
DELISTED
Heska Corp
HSKA
| $5.24M | 1.94% | +84,309 | New | +$5.24M |
|
13
Protagonist Therapeutics
PTGX
$3.67B
| $4.74M | 1.75% | +434,635 | New | +$4.74M |
|
14
Novavax
NVAX
$1.21B
| $3.5M | 1.29% | +340,000 | New | +$3.5M |
|
|
CBAY
15
DELISTED
Cymabay Therapeutics
CBAY
| $3.48M | 1.29% | 555,610 | – | – |
|
16
Pharvaris
PHVS
$1.39B
| $3.21M | 1.19% | +285,000 | New | +$3.21M |
|
|
MACK
17
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $2.87M | 1.06% | +250,000 | New | +$2.87M |
|
18
Orchestra BioMed
OBIO
$147M
| $2.5M | 0.92% | 250,000 | – | – |
|
|
EUCRU
19
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $2.48M | 0.92% | 248,674 | – | – |
|
|
CTIC
20
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.98M | 0.73% | +330,000 | New | +$1.98M |
|
21
X4 Pharmaceuticals
XFOR
$84.2M
| $1.81M | 0.67% | 1,825,963 +407,502 | +29% | +$405K |
|
22
Modular Medical
MODD
$39.9M
| $1.38M | 0.51% | 689,352 +115,000 | +20% | +$230K |
|
23
Merus
MRUS
$4.98B
| $1.36M | 0.5% | 87,953 | – | – |
|
24
Spyre Therapeutics
SYRE
$996M
| $1.35M | 0.5% | 3,004,959 -1,663,577 | -36% | -$748K |
|
25
Savara
SVRA
$567M
| $1.34M | 0.5% | 866,448 +10,020 | +1% | +$15.5K |
|